Please note that currently answers can be provided only in English, German and French.


(+43) 720 778105


(+32) 7848 27 51

Bulgaria (+359) 2 437 2216


(+357) 22 050803

Czech Republic

(+42) 0228 882 214


(+45) 89 88 83 53


(+372) 880 1200


(+358) 753 252 569


(+33) 184 88 80 69


(+49) 893 803 6915


(+30) 211 199 1587

Hungary (+36) 1 655 5394


(+354) 539 0641

Republic of Ireland

(+353) 1903 9713


(+39) 02 82952389


(+371) 6458 8839


(+370) 5214 0410


(+352) 27 867 570


(+356) 2778 1217


(+31) 202 419041


(+47) 800 25 129


(+48) 22 104 09 49


(+351) 211 451 261


(+40) 376 300 296


(+421) 233 056 859


(+386) 828 80 050


(+34) 919 011 012


(+46) 108 885 437


(+41) 31 528 08 44

United Kingdom (+44) 330 818 0490

Our offices are open Monday to Friday. 

  • For support in English 09:00 – 17:00 GMT 
  • For support in French and German 09:00 – 17:00 CET  

In addition, our offices will be closed on the following dates: 


  • 1 January 
  • 3 March 
  • 10 April 
  • 13 April 
  • 17 April 
  • 20 April 
  • 1 May
  • 6 May
  • 8 May
  • 25 May
  • 31 August
  • 7 September
  • 22 September  
  • 24 December
  • 25 December 
  • 28 December 

If you are experiencing a medical emergency, please contact your healthcare professional.

Seattle Genetics is committed to producing to the highest possible standards. In case you experience any deficiencies related to the identity, quality, reliability, safety, effectiveness, or performance of a Seattle Genetics product please report this to us immediately.
To make a complaint regarding one of our products, please contact our Medical Information Contact Centre or directly email us at:

Reporting Side Effects

Ensuring patient safety is important to Seattle Genetics and we take the safety of our medicines seriously. Seattle Genetics monitors the safety of all its medicinal products continuously, not only in the clinical trial stage, but also after bringing the product to the market. We collect information and experiences from patients and health care providers regarding side effects to be able to provide better safety information on our products for patients.

If a medicinal product causes a side effect, please contact our Medical Information Contact Centre or directly email us at

Seattle Genetics may contact you for more information concerning your report. However, we are unable to provide medical advice regarding your condition.

If you are concerned in any way about your treatment, you should contact your healthcare professional.



Seagen B.V. (“Seagen”) will electronically process and store the following categories of personal data in its systems:
personal details (e.g. name, gender, date of birth), contact details (e.g. email address, telephone number(s), country), professional qualifications, institute and other professional affiliations (e.g. department, function, specialty).

If you contact us to ask for information on our products or to report an adverse event, we may also collect information about your health or other sensitive data.

This information is only processed when relevant and necessary to document your reaction properly and for the purpose of meeting our pharmacovigilance, safety, and any other legal requirements.


In case of a medical enquiry, your personal data may be used to answer your inquiry, follow up on said request and maintain the information in a medical information database for reference.

In case of an adverse event reporting, we need to be able to get in touch with people who contact us in order to follow-up and, if needed, obtain further information, give answers to requests or to send requested material.

In case of communications about our products, the information will be used only  for that purpose (e.g. evaluation, classification and assessment of the product complaint, to follow up on such requests and to maintain the information in a product complaints database for reference).


The processing of your personal data will be based on our willingness and obligation to ensure high standards of quality and safety of medicinal products and the articles 6.1(c), 6.1(f) and 9.2(i) of the GDPR (the General Data Protection Regulation 2016/679).

The processing may also be based on your consent to said processing and the article 9.2(a) of the GDPR.


The entity responsible to collect and process your data is Seagen B.V., with registered office in Evert van de Beekstraat 1, 140, 1118CL Schiphol (Netherlands).

You can use this address or the email address to contact us.

Since Seagen is a part of an international group of companies and some of them perform services for us, Seagen may also have to transfer your data to companies of the Seattle Genetics group.

Seagen may also have to share your data with services providers (e.g. Medical Information Call Centers).

In cases when an adverse event is reported, we will have to share your data with health authorities (such as the European Medicines Agency) to allow them to evaluate adverse events and make efforts to prevent similar events from happening in the future, however note that in these circumstances we do not share any information that directly identifies any individual (such as names or contact information), but we only share pseudonymised information.


Companies of the Seattle Genetics group or service providers may be located in Switzerland or countries of the EEA (European Economic Area).

We may also have to transfer your data to our parent company in US: this will happen regularly for pharmacovigilance purposes, while only occasionally in case of medical enquiries or product complaints.

The US are among those countries that are not considered by the EU Commission as offering adequate protection to personal data, that is to say that, according to the Commission, the data processing measures adopted in the US are not as secure as the one adopted in the EEA.

When we transfer personal data out of the EEA to other countries that have not been deemed adequate, Seagen ensures that this will only happen in compliance with the law and with appropriate safeguards pursuant to art. 49.1(a) GDPR.


For adverse reporting, in accordance with law, pharmaceutical companies, as market authorisation holders of products, must retain all product-related documents for at least the time period of the market authorisation, plus 10 years following its expiry. Therefore, personal information related to the safety of our products will be retained for this time period. 

For medical information enquiries and product complaints, personal information will be retained for a maximum of 5 years from the moment of collection.


You may be entitled under applicable law to ask Seagen for a copy of your information, to correct it, erase or restrict its processing. You may also have rights to object to some processing and withdraw your consent where applicable, however these rights may be limited in some situations – for example, where we have a legal requirement to process or keep your personal data.

Please note that for legal reasons, we cannot delete information that has been collected as part of an adverse event report unless it is inaccurate. Also, we may require you to provide proper identification before we comply with any request to access or correct personal data.

You can exercise your rights by using the email address


We wish to remind you that you can lodge a complaint with your country’s Data Protection Supervisory Authority, should you have legitimate reasons to complain about the processing of your data by Seagen.